Picture of Galenica AG logo

GALE — Galenica AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Galenica H1 Adjusted2 EBIT Down 1.4% At CHF 100.0 Mln

Aug 9 (Reuters) - GALENICA AG  GALE.S :
    * GALENICA GROWS STRONGLY IN THE FIRST HALF OF 2022 AND
RAISES ITS
OUTLOOK
    * H1 GENERATED CONSOLIDATED NET SALES OF CHF 1,959.9
MILLION,
REPRESENTING STRONG GROWTH OF 5.5% COMPARED TO THE FIRST HALF OF
2021
    * H1 THE OPERATING RESULT (EBIT) IMPROVED BY 4.4% TO CHF
103.3
MILLION
    * H1 ADJUSTED2 EBIT FELL BY 1.4% TO CHF 100.0 MILLION
    * COMPARED TO THE PRIOR-YEAR PERIOD, ADJUSTED2 RETURN ON
SALES
(ROS) FELL FROM 5.5% TO 5.1%
    * NOW EXPECTS SALES GROWTH OF BETWEEN 2% AND 4% (PREVIOUSLY
AT
LEAST AT THE SAME LEVEL AS THE PREVIOUS YEAR)
    * EXPECTS AN EBIT INCREASE OF 8% TO 12% (PREVIOUSLY 5% TO
10%)
    * H1 ADJUSTED NET PROFIT CHF 81.3 MILLION

Source text for Eikon: [ID: https://www.galenica.com/en/media/media-releases/2022/halbjahresergebnisse-2022.php
]
Further company coverage:  GALE.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Galenica AG

See all news